A Phase 2 Open Label, Single Arm Pilot Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Jan 2018
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Skin disorders
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 11 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 11 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Sep 2018.
- 31 Oct 2017 Status changed from recruiting to active, no longer recruiting.